JAGUAR HEALTH, INC. Basic Shares Outstanding (Weighted Average)
JAGUAR HEALTH, INC. (JAGX) reported Basic Shares Outstanding (Weighted Average) of 809.12 thousand shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-19
- JAGUAR HEALTH, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 809.12K shares, a 2690.65% increase year-over-year.
- JAGUAR HEALTH, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 515.79K shares, a 2780.85% increase year-over-year.
- JAGUAR HEALTH, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 5.30M shares, a 769.54% increase year-over-year.
- JAGUAR HEALTH, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 1.51M shares, a 303.72% increase year-over-year.
- JAGUAR HEALTH, INC. weighted average number of shares outstanding, basic for fiscal 2025 was 2.33M shares, a 691.90% increase from fiscal 2024.
- JAGUAR HEALTH, INC. weighted average number of shares outstanding, basic for fiscal 2024 was 294.53K shares, a 1809.95% increase from fiscal 2023.
- JAGUAR HEALTH, INC. weighted average number of shares outstanding, basic for fiscal 2023 was 15.42K shares, a 98.82% decline from fiscal 2022.
- JAGUAR HEALTH, INC. weighted average number of shares outstanding, basic for fiscal 2022 was 1.31M shares, a 120.00% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month | Weighted Average Number of Shares Outstanding, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 809.12K shares 10-Q · filed 2026-08-19 | 561.57K shares 10-Q · filed 2026-08-19 | 2.21M shares derived: average of 3 quarters · filed 2026-08-19 | 2.03M shares derived: average of 4 quarters · filed 2026-08-19 | ||||
| 2026-03-31 | 515.79K shares 10-Q · filed 2026-05-20 | 2.91M shares derived: average of 2 quarters · filed 2026-05-20 | 2.44M shares derived: average of 3 quarters · filed 2026-05-20 | 1.84M shares derived: average of 4 quarters · filed 2026-08-19 | ||||
| 2025-12-31 | 5.30M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-07 | 3.41M shares derived: average of 2 quarters · filed 2026-04-07 | 2.28M shares derived: average of 3 quarters · filed 2026-08-19 | 2.33M shares 10-K · filed 2026-04-07 | ||||
| 2025-09-30 | 1.51M shares 10-Q · filed 2025-11-14 | 771.09K shares derived: average of 2 quarters · filed 2026-08-19 | 1.34M shares 10-Q · filed 2025-11-14 | 542.38K shares derived: average of 4 quarters · filed 2026-08-19 | ||||
| 2025-06-30 | 28.99K shares 10-Q · filed 2026-08-19 | 1.01M shares 10-Q · filed 2025-08-14 | 22.27K shares 10-Q · filed 2026-08-19 | 779.39K shares 10-Q · filed 2025-08-14 | 218.78K shares derived: average of 3 quarters · filed 2026-08-19 | 257.78K shares derived: average of 4 quarters · filed 2026-08-19 | ||
| 2025-03-31 | 17.90K shares 10-Q · filed 2026-05-20 | 626.64K shares 10-Q · filed 2025-05-15 | 313.67K shares derived: average of 2 quarters · filed 2026-05-20 | 334.05K shares derived: average of 3 quarters · filed 2026-05-20 | 1.14M shares derived: average of 4 quarters · filed 2026-05-20 | |||
| 2024-12-31 | 609.43K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-07 | 492.12K shares derived: average of 2 quarters · filed 2026-04-07 | 1.52M shares derived: average of 3 quarters · filed 2026-04-07 | 294.53K shares 10-K · filed 2026-04-07 | ||||
| 2024-09-30 | 374.81K shares 10-Q · filed 2025-11-14 | 9.37M shares 10-Q · filed 2024-11-13 | 1.97M shares derived: average of 2 quarters · filed 2025-11-14 | 189.57K shares 10-Q · filed 2025-11-14 | 5.85M shares 10-Q · filed 2024-11-13 | 846.96K shares derived: average of 4 quarters · filed 2025-11-14 | ||
| 2024-06-30 | 3.57M shares 10-Q · filed 2025-08-14 | 2.35M shares 10-Q · filed 2024-08-13 | 2.40M shares 10-Q · filed 2025-08-14 | 1.17M shares 10-Q · filed 2024-08-13 | 1.00M shares derived: average of 3 quarters · filed 2025-08-14 | 839.68K shares derived: average of 4 quarters · filed 2025-08-14 | ||
| 2024-03-31 | 105.89K shares 10-Q · filed 2025-05-15 | 158.84M shares 10-Q · filed 2024-05-14 | -279.97K shares derived: average of 2 quarters · filed 2025-05-15 | -71.43K shares derived: average of 3 quarters · filed 2025-05-15 | 19.90K shares derived: average of 4 quarters · filed 2025-05-15 | |||
| 2023-12-31 | -665.83K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -160.09K shares derived: average of 2 quarters · filed 2025-03-31 | -8.77K shares derived: average of 3 quarters · filed 2025-03-31 | 15.42K shares 10-K · filed 2025-03-31 | 23.07M shares 10-K · filed 2024-04-01 | |||
| 2023-09-30 | 345.66K shares 10-Q · filed 2024-11-13 | 20.74M shares 10-Q · filed 2023-11-14 | 319.76K shares derived: average of 2 quarters · filed 2024-11-13 | 242.50K shares 10-Q · filed 2024-11-13 | 14.55M shares 10-Q · filed 2023-11-14 | 1.93M shares derived: average of 4 quarters · filed 2024-11-13 | ||
| 2023-06-30 | 293.86K shares 10-Q · filed 2024-08-13 | 17.63M shares 10-Q · filed 2023-08-14 | 190.07K shares 10-Q · filed 2024-08-13 | 11.41M shares 10-Q · filed 2023-08-14 | 2.46M shares derived: average of 3 quarters · filed 2024-08-13 | 2.20M shares derived: average of 4 quarters · filed 2024-08-13 | ||
| 2023-03-31 | 5.11M shares 10-Q · filed 2024-05-14 | 3.54M shares derived: average of 2 quarters · filed 2024-05-14 | 2.84M shares derived: average of 3 quarters · filed 2024-05-14 | 2.39M shares derived: average of 4 quarters · filed 2024-05-14 | ||||
| 2022-12-31 | 1.98M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | 1.70M shares derived: average of 2 quarters · filed 2024-04-01 | 1.49M shares derived: average of 3 quarters · filed 2024-04-01 | 1.31M shares 10-K · filed 2024-04-01 | ||||
| 2022-09-30 | 1.42M shares 10-Q · filed 2023-11-14 | 106.36M shares 10-Q · filed 2022-11-14 | 1.24M shares derived: average of 2 quarters · filed 2023-11-14 | 1.09M shares 10-Q · filed 2023-11-14 | 81.66M shares 10-Q · filed 2022-11-14 | -31.71M shares derived: average of 4 quarters · filed 2023-11-14 | ||
| 2022-06-30 | 1.07M shares 10-Q · filed 2023-08-14 | 79.70M shares 10-Q · filed 2022-08-22 | 927.04K shares 10-Q · filed 2023-08-14 | 69.11M shares 10-Q · filed 2022-08-22 | -42.76M shares derived: average of 3 quarters · filed 2023-08-14 | -20.61M shares derived: average of 4 quarters · filed 2023-08-14 | ||
| 2022-03-31 | 778.51K shares 10-Q · filed 2023-05-15 | 44.71M shares 10-Q · filed 2022-05-10 | -64.67M shares derived: average of 2 quarters · filed 2023-05-15 | -27.83M shares derived: average of 3 quarters · filed 2023-05-15 | -9.61M shares derived: average of 4 quarters · filed 2023-05-15 | |||
| 2021-12-31 | -130.12M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-24 | -42.14M shares derived: average of 2 quarters · filed 2023-03-24 | -13.08M shares derived: average of 3 quarters · filed 2023-03-24 | 596.15K shares 10-K · filed 2023-03-24 | 44.71M shares 10-K · filed 2022-03-11 | |||
| 2021-09-30 | 45.84M shares 10-Q · filed 2022-11-14 | 45.44M shares derived: average of 2 quarters · filed 2022-11-14 | 44.17M shares 10-Q · filed 2022-11-14 | 39.64M shares derived: average of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | 45.04M shares 10-Q · filed 2022-08-22 | 134.44M shares 10-Q · filed 2021-08-13 | 43.57M shares 10-Q · filed 2022-08-22 | 129.95M shares 10-Q · filed 2021-08-13 | 37.58M shares derived: average of 3 quarters · filed 2022-08-22 | 31.54M shares derived: average of 4 quarters · filed 2022-08-22 | ||
| 2021-03-31 | 42.64M shares 10-Q · filed 2022-05-10 | 33.85M shares derived: average of 2 quarters · filed 2022-05-10 | 27.03M shares derived: average of 3 quarters · filed 2022-05-10 | 26.25M shares derived: average of 4 quarters · filed 2022-05-10 | ||||
| 2020-12-31 | 25.06M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | 19.23M shares derived: average of 2 quarters · filed 2022-03-11 | 20.78M shares derived: average of 3 quarters · filed 2022-03-11 | 12.88M shares 10-K · filed 2022-03-11 | ||||
| 2020-09-30 | 13.41M shares 10-Q · filed 2021-11-17 | 18.65M shares derived: average of 2 quarters · filed 2021-11-17 | 8.82M shares 10-Q · filed 2021-11-17 | |||||
| 2020-06-30 | 23.89M shares 10-Q · filed 2021-08-13 | 19.52M shares 10-Q · filed 2021-08-13 | ||||||
| 2018-09-30 | 12.06M shares 10-Q · filed 2018-11-19 | 10.70M shares 10-Q · filed 2018-11-19 | ||||||
| 2018-03-31 | 129.47M shares 10-Q · filed 2018-05-15 | |||||||
| 2017-09-30 | 3.70M shares 10-Q · filed 2018-11-19 | 55.43M shares 10-Q · filed 2017-11-20 | 1.88M shares 10-Q · filed 2018-11-19 | 28.25M shares 10-Q · filed 2017-11-20 | ||||
| 2017-03-31 | 14.16M shares 10-Q · filed 2018-05-15 | |||||||
| 2016-09-30 | 11.26M shares 10-Q · filed 2017-11-20 | 10.30M shares 10-Q · filed 2017-11-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |